Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 361Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Lymphoma 297Leukemia 254Multiple Myeloma 246Leukemia, Myeloid, Acute 241Lymphoma, Non-Hodgkin 240Lymphoma, Large B-Cell, Diffuse 238Leukemia, Lymphocytic, Chronic, B-Cell 220Myelodysplastic Syndromes 184Lymphoma, Follicular 176Hodgkin Disease 165Lymphoma, Mantle-Cell 163Burkitt Lymphoma 160Lymphoma, B-Cell, Marginal Zone 117Recurrence 115Lymphoma, Large-Cell, Immunoblastic 95Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Myeloproliferative Disorders 81Melanoma 78Neoplasms, Plasma Cell 77Leukemia, Myeloid, Chronic-Phase 72Hematologic Neoplasms 72Leukemia, Myeloid, Accelerated Phase 71Leukemia, Myelomonocytic, Chronic 69Lymphoma, B-Cell 65Dendritic Cell Sarcoma, Interdigitating 64Triple Negative Breast Neoplasms 63Ovarian Neoplasms 61Congenital Abnormalities 59

Interventions

Docetaxel 3Prednisone 2sargramostim 1epothilone B 1cabazitaxel 1Sunitinib 1PE regimen 1Interleukin-2 1Injections 1Everolimus 1Etoposide 1Cyclophosphamide 1Cisplatin 1Carboplatin 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hormone Refractory Prostate Cancer × Cyclophosphamide × Clear all
NCT02867345 2019-03-06

PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer

Peking University

Withdrawn
Genitourinary

Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡